Discovery of Indazole-Based Selective IRAK4 Inhibitors

Please copy the URL and add it into your RSS Feed Reader.

Facebook X Linkedin Weibo

Download PDF

Synfacts 2024; 20(04): 0421
DOI: 10.1055/s-0043-1763684

Innovative Drug Discovery and Development

Contributor(s):

Antonia F. Stepan (Roche)

,

Seong Heon Kim (Hyundai Pharm)

IRAK4 - indazoles - inflammatory diseases - BAY1830839 - BAY1834845 - zabedosertib - clinical candidates

Article published online:
13 March 2024

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany